Follow
Gunnstein Norheim
Gunnstein Norheim
Director Infectious Diseases, Vaccibody
Verified email at vaccibody.com - Homepage
Title
Cited by
Cited by
Year
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial …
AM Henao-Restrepo, A Camacho, IM Longini, CH Watson, WJ Edmunds, ...
The Lancet 389 (10068), 505-518, 2017
10732017
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
AM Henao-Restrepo, IM Longini, M Egger, NE Dean, WJ Edmunds, ...
The Lancet 386 (9996), 857-866, 2015
8882015
Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient
V Eldholm, G Norheim, B von der Lippe, W Kinander, UR Dahle, ...
Genome biology 15 (11), 1-11, 2014
1842014
Molecular epidemiology of Neisseria meningitidis isolated in the African meningitis belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes
P Nicolas, G Norheim, E Garnotel, S Djibo, DA Caugant
Journal of clinical microbiology 43 (10), 5129-5135, 2005
1362005
Emergence of serogroup X meningococcal disease in Africa: need for a vaccine
O Xie, AJ Pollard, JE Mueller, G Norheim
Vaccine 31 (27), 2852-2861, 2013
1342013
The concept of “tailor-made”, protein-based, outer membrane vesicle vaccines against meningococcal disease
J Holst, B Feiring, LM Næss, G Norheim, P Kristiansen, EA Høiby, K Bryn, ...
Vaccine 23 (17-18), 2202-2205, 2005
1252005
The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola
Ebola ça Suffit Ring Vaccination Trial Consortium
BMJ: British Medical Journal 351, h3740, 2015
1222015
Mycobacterium tuberculosis lineage 7 strains are associated with prolonged patient delay in seeking treatment for pulmonary tuberculosis in Amhara Region, Ethiopia
SA Yimer, G Norheim, A Namouchi, ED Zegeye, W Kinander, T Tønjum, ...
Journal of clinical microbiology 53 (4), 1301-1309, 2015
942015
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X
F Micoli, MR Romano, M Tontini, E Cappelletti, M Gavini, D Proietti, ...
Proceedings of the National Academy of Sciences 110 (47), 19077-19082, 2013
772013
Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis
G Norheim, A Aase, DA Caugant, EA Høiby, E Fritzsønn, T Tangen, ...
Vaccine 23 (29), 3762-3774, 2005
512005
Developing vaccines against epidemic-prone emerging infectious diseases
V Bernasconi, PA Kristiansen, M Whelan, RG Román, A Bettis, SA Yimer, ...
Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 63 (1), 65-73, 2020
432020
A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial
L Marsay, C Dold, CA Green, CS Rollier, G Norheim, M Sadarangani, ...
Journal of Infection 71 (3), 326-337, 2015
422015
Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies
O Xie, B Bolgiano, F Gao, K Lockyer, C Swann, C Jones, I Delrieu, ...
Vaccine 30 (40), 5812-5823, 2012
422012
Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989
G Norheim, E Rosenqvist, A Aseffa, MA Yassin, G Mengistu, A Kassu, ...
Journal of clinical microbiology 44 (3), 861-871, 2006
422006
Rift valley fever: diagnostic challenges and investment needs for vaccine development
V Petrova, P Kristiansen, G Norheim, SA Yimer
BMJ Global Health 5 (8), e002694, 2020
412020
Ample glycosylation in membrane and cell envelope proteins may explain the phenotypic diversity and virulence in the Mycobacterium tuberculosis complex
AG Birhanu, SA Yimer, S Kalayou, T Riaz, ED Zegeye, C Holm-Hansen, ...
Scientific reports 9 (1), 1-15, 2019
402019
Nε- and O-Acetylation in Mycobacterium tuberculosis Lineage 7 and Lineage 4 Strains: Proteins Involved in Bioenergetics, Virulence, and Antimicrobial …
AG Birhanu, SA Yimer, C Holm-Hansen, G Norheim, A Aseffa, M Abebe, ...
Journal of proteome research 16 (11), 4045-4059, 2017
342017
An Outer Membrane Vesicle Vaccine for Prevention of Serogroup A and W‐135 Meningococcal Disease in the African Meningitis Belt
G Norheim, G Tunheim, LM Naess, PA Kristiansen, DA Caugant, ...
Scandinavian journal of immunology 76 (2), 99-107, 2012
332012
Tuberculosis outbreak in an educational institution in Norway
G Norheim, S Seterelv, TM Arnesen, AT Mengshoel, T Tønjum, ...
Journal of clinical microbiology 55 (5), 1327-1333, 2017
312017
Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens
JC Nagaputra, CS Rollier, M Sadarangani, JC Hoe, OH Mehta, ...
Clinical and Vaccine Immunology 21 (2), 234-242, 2014
292014
The system can't perform the operation now. Try again later.
Articles 1–20